Approval · Notice of Compliance 19991 · 2017

PREVYMIS: Notice of Compliance 19991

Issued November 1, 2017

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 19991
Date: November 1, 2017
Company: Merck Canada IncKirkland, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Priority-NAS

Products in this notice

Brand	DIN	Status today
PREVYMIS	02469405	Cancelled Post Market
PREVYMIS	02469375	Marketed
PREVYMIS	02469383	Marketed
PREVYMIS	02469367	Marketed

Medicinal ingredients

LETERMOVIR 480 MG per VIAL
LETERMOVIR 240 MG per TAB
LETERMOVIR 480 MG per TAB
LETERMOVIR 240 MG per VIAL